Yoichi Mashimo
Overview
Explore the profile of Yoichi Mashimo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
551
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimizu N, Mashimo Y, Yokouchi H, Nishio Y, Sawai S, Ichikawa T, et al.
J Hum Genet
. 2025 Feb;
70(4):199-205.
PMID: 39939800
Mutations in fibrillin-1 (FBN1) cause various clinical conditions, such as Marfan syndrome (MFS). However, the genotype-phenotype relationships underlying MFS and other conditions relevant to FBN1 mutations have not been fully...
2.
Saito Y, Shimizu N, Mashimo Y, Tatsumi T, Yokouchi H, Baba T
Cureus
. 2025 Jan;
16(12):e75295.
PMID: 39776715
Objectives This study aimed to identify the etiology and the direction of dislocation of the natural crystalline lens or intraocular lens (IOL) in IOL intrascleral fixation surgery and to determine...
3.
Nakamura H, Kikuchi A, Sakai H, Kamimura M, Watanabe Y, Onuma R, et al.
Front Pediatr
. 2024 Mar;
12:1340263.
PMID: 38510083
Background: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA syndrome), and Kawasaki disease (KD) are both considered to be disorders of the innate immune system, and the potential role...
4.
Fukunaga K, Tsukagoshi E, Kurata M, Mizukawa Y, Niihara H, Morita E, et al.
J Invest Dermatol
. 2023 Nov;
144(4):908-911.e7.
PMID: 37914023
No abstract available.
5.
Nakamura R, Arakawa N, Tanaka Y, Uchiyama N, Sekine A, Mashimo Y, et al.
Hepatol Res
. 2022 Dec;
53(5):440-449.
PMID: 36583370
Aim: Drug-induced liver injury (DILI) is a severe and life-threatening immune-mediated adverse effect, occurring rarely among treated patients. We examined genomic biomarkers in the Japanese population that predict the onset...
6.
Mashimo Y, Yamazaki K, Kageyama T, Tanaka S, Taniguchi T, Matsushita K, et al.
J Infect
. 2022 Nov;
85(6):702-769.
PMID: 36341890
No abstract available.
7.
Kim C, Kang D, Callaway Z, Kim K, Kwon E, Yamaide F, et al.
Asia Pac Allergy
. 2022 Aug;
12(3):e25.
PMID: 35966157
Background: Eosinophils are major effector cells of allergic disease and excellent markers of eosinophilic inflammation. Accurate and reliable biomarkers are helpful in the diagnosis, treatment, and control of allergic disease....
8.
Kondo H, Kageyama T, Tanaka S, Otsuka K, Tsukumo S, Mashimo Y, et al.
Front Immunol
. 2022 May;
13:836923.
PMID: 35572546
BNT162b2, a nucleoside-modified mRNA vaccine for SARS-CoV-2 spike glycoprotein (S), provides approximately 95% efficacy for preventing COVID-19. However, it remains unclear how effectively memory CD8+ T cells are generated and...
9.
Sakurai-Yageta M, Mashimo Y, Kuroishi T, Ishihara R, Shimojo N, Kohno Y, et al.
J Nutr Sci Vitaminol (Tokyo)
. 2021 Sep;
67(4):211-216.
PMID: 34470995
Biotin is a water-soluble B complex vitamin and coenzyme of five types of carboxylase and plays crucial roles in fatty acid, glucose, and amino acid metabolism. Nutritional biotin deficiency and...
10.
Johnson T, Mashimo Y, Wu J, Yoon D, Hata A, Kubo M, et al.
J Hum Genet
. 2020 Oct;
66(5):475-489.
PMID: 33106546
In a meta-analysis of three GWAS for susceptibility to Kawasaki disease (KD) conducted in Japan, Korea, and Taiwan and follow-up studies with a total of 11,265 subjects (3428 cases and...